Risk Factors for Postoperative Nausea and Vomiting After Nasal Surgery Under General Anesthesia
N-PONV
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
The goal of this observational study is to learn how often postoperative nausea and vomiting occur in adults undergoing nasal surgery under general anesthesia and to identify factors associated with these events. The study will also describe other postoperative complications and factors that may affect recovery. The main questions it aims to answer are:
- How many participants experience nausea, retching, or vomiting within 24 hours after surgery?
- Which patient characteristics, anesthesia-related factors, surgical factors, and perioperative medications are associated with postoperative nausea and vomiting?
- What other postoperative complications and nasal-related symptoms occur after surgery? Approximately 1,000 adults undergoing nasal surgery under general anesthesia at three hospitals in China will be enrolled. This is an observational study, and participation will not change the anesthesia, surgery, medications, or other medical care selected by the treating clinical team. Participants will:
- Complete assessments before surgery about their medical history, previous nausea or vomiting, anxiety, sleep, and recovery status
- Receive routine anesthesia and surgical care
- Be assessed for nausea, retching, vomiting, pain, nasal discomfort, and other complications during the first 24 hours after surgery
- Complete follow-up assessments after surgery, including follow-up by telephone after discharge, for up to 6 months The study will use information from participant questionnaires, medical records, anesthesia records, and postoperative follow-up assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
August 6, 2026
August 1, 2026
5 months
July 20, 2026
August 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Postoperative Nausea and Vomiting Within 24 Hours
The proportion of participants who experience any episode of nausea, retching, or vomiting during the first 24 hours after surgery. Postoperative nausea and vomiting will be assessed during the following intervals: 0-2 hours, 2-6 hours, 6-12 hours, and 12-24 hours after anesthesia induction. A participant will be considered to have postoperative nausea and vomiting if nausea, retching, or vomiting occurs at any time during the 24-hour observation period.
From the end of surgery through 24 hours after surgery
Secondary Outcomes (13)
Incidence of Clinically Significant Postoperative Nausea and Vomiting
At 6 hours, 24 hours, and postoperative day 3
Incidence of Vomiting or Retching Within 24 Hours
From the end of surgery through 24 hours after surgery
Number of Vomiting or Retching Episodes Within 24 Hours
From the end of surgery through 24 hours after surgery
Use of Rescue Antiemetic Medication
From the end of surgery through postoperative day 3
Severity of Postoperative Pain
At 0-2 hours, 2-6 hours, 6-12 hours, 12-24 hours, postoperative day 3, and postoperative day 30
- +8 more secondary outcomes
Study Arms (1)
Adults Undergoing Nasal Surgery Under General Anesthesia
This prospective observational cohort includes adults aged 18 years or older undergoing nasal surgery under general anesthesia. No study-specific intervention will be administered. Anesthetic management, surgical care, prophylactic antiemetic therapy, analgesia, and postoperative treatment will be determined by routine clinical practice at each participating center. Perioperative patient, anesthesia, surgical, and medication-related factors will be recorded, and participants will be followed to assess postoperative nausea and vomiting and other postoperative complications.
Eligibility Criteria
The study population consists of adult patients (≥18 years) scheduled to undergo elective nasal surgery under general anesthesia at three tertiary hospitals in China. Consecutive eligible patients who provide written informed consent will be enrolled in this multicenter prospective observational cohort study to evaluate the incidence and risk factors for postoperative nausea and vomiting.
You may qualify if:
- Scheduled to undergo nasal surgery under general anesthesia
- Aged 18 years or older
- Willing and able to provide written informed consent
You may not qualify if:
- Unable to cooperate with study procedures or complete study assessments for any reason, including language barriers, cognitive impairment, or inability to complete the questionnaires
- Considered unsuitable for participation by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Chief Physician, Director of the Department of Anesthesiology
Study Record Dates
First Submitted
July 20, 2026
First Posted
August 6, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR, ANALYTIC CODE
De-identified individual participant data will be shared through the SDB platform (https://www.scidb.cn/en) under controlled access. Access will be granted to qualified researchers whose research proposals are scientifically and ethically appropriate and approved according to the SDB data access procedures. Data users may be required to sign a data use agreement before access is granted.